Literature DB >> 7579343

In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids.

C Grosset1, B Jazwiec, J L Taupin, H Liu, S Richard, F X Mahon, J Reiffers, J F Moreau, J Ripoche.   

Abstract

Endothelial cell (EC) may represent a major source of cytokines in the bone marrow. In this study we have examined the production and the regulation of the production of leukemia inhibitory factor/human interleukin for DA cells (LIF/HILDA) by EC. Human umbilical vein endothelial cells (HUVEC) were chosen as a working model as they are a well known source of cytokines. These cells secrete LIF/HILDA (90 pg/mL/10(6) cells/48 h) in basal conditions. This secretion is profoundly altered by interleukin-1 alpha (IL-1 alpha). Secretion of LIF/HILDA is increased threefold on stimulation with IL-1 alpha at a concentration of 100 IU/mL. The secreted protein is bioactive as demonstrated by its proliferative effects on DA1a cells. Modulation of the production of LIF/HILDA by glucocorticoids (GC) was also examined. In striking contrast to what was observed for IL-1 alpha, the synthetic GC dexamethasone (DXM) at a concentration of 10(-6) mol/L consistently inhibited the basal secretion of LIF/HILDA by an average of threefold and suppressed the IL-1 alpha-induced increase of the secretion of this cytokine by HUVEC. In an effort to extend results obtained with HUVEC to the bone marrow endothelium, we have also examined the production of LIF/HILDA by human bone marrow endothelial cells (HBMEC). Our study shows that HBMEC are quantitatively a very important source of this cytokine (above 7.25 ng/mL/10(6) cells/48 h) suggesting that they are a major source of LIF/HILDA in the bone marrow. Again, IL-1 alpha proved to be a very potent stimulus for the secretion of LIF/HILDA and synthetic GC such as DXM when used at a concentration of 10(-6) mol/L inhibited by an average of threefold the basal secretion of LIF/HILDA and had suppressive effect on the IL-1 alpha-induced increase of this secretion. The downregulation of LIF/HILDA production in the bone marrow by GC may be important to understand the effects of GC on hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579343

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Optimization of use of UEA-1 magnetic beads for endothelial cell isolation.

Authors:  V Conrad-Lapostolle; L Bordenave; C Baquey
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

2.  Ability of various inserts to promote endothelium cell culture for the establishment of coculture models.

Authors:  F Villars; V Conrad; F Rouais; F Lefebvre; J Amédée; L Bordenave
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

3.  Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.

Authors:  Maobin Yang; Lorin B Trettel; Douglas J Adams; John R Harrison; Ernesto Canalis; Barbara E Kream
Journal:  Bone       Date:  2010-06-09       Impact factor: 4.398

4.  Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis.

Authors:  Ming Ruan; Larry Pederson; Elizabeth W Bradley; Ana-Maria Bamberger; Merry Jo Oursler
Journal:  Endocrinology       Date:  2010-02-24       Impact factor: 4.736

5.  Induction of astrocyte differentiation by endothelial cells.

Authors:  H Mi; H Haeberle; B A Barres
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.